Cargando…
Evaluation of the safety, tolerability, and pharmacokinetics of RO7049389 in healthy Chinese volunteers
The objectives of this phase I study are to assess the safety, tolerability, and pharmacokinetics (PKs) of RO7049389 in healthy Chinese volunteers (HVs) and evaluate potential ethnic differences in the safety and PKs using data from this study and the first‐in‐human study (in which most of the HVs w...
Autores principales: | Wu, Xiaojie, Feng, Sheng, Zhang, Jing, Zhang, Wenhong, Zhang, Yuchen, Zhu, Mingfen, Triyatni, Miriam, Zhao, Na, Bo, Qingyan, Jin, Yuyan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8742633/ https://www.ncbi.nlm.nih.gov/pubmed/34562067 http://dx.doi.org/10.1111/cts.13134 |
Ejemplares similares
-
How Semiphysiological Population Pharmacokinetic Modeling Incorporating Active Hepatic Uptake Supports Phase II Dose Selection of RO7049389, A Novel Anti–Hepatitis B Virus Drug
por: Cosson, Valérie, et al.
Publicado: (2021) -
A single ascending dose study of single‐stranded oligodeoxyribonucleotide RO7062931 in Chinese healthy volunteers
por: Cheung, Tsang Tommy, et al.
Publicado: (2023) -
A Single and Multiple Ascending Dose Study of Toll‐Like Receptor 7 Agonist (RO7020531) in Chinese Healthy Volunteers
por: Luk, Andrea, et al.
Publicado: (2020) -
Safety, tolerability, pharmacokinetics, and pharmacodynamics of a TLR7 agonist prodrug RO6870868 in healthy volunteers
por: Grippo, Joseph F., et al.
Publicado: (2021) -
Clinical Study of Single‐Stranded Oligonucleotide RO7062931 in Healthy Volunteers and Patients With Chronic Hepatitis B
por: Gane, Edward, et al.
Publicado: (2021)